Form 8-K

8-K — CROSS COUNTRY HEALTHCARE INC

Accession: 0000950103-26-011218

Filed: 2026-07-28

Period: 2026-07-21

CIK: 0001141103

SIC: 7363 (SERVICES-HELP SUPPLY SERVICES)

Item: Termination of a Material Definitive Agreement

Item: Completion of Acquisition or Disposition of Assets

Item: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item: Material Modifications to Rights of Security Holders

Item: Changes in Control of Registrant

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — dp250670_8k.htm (Primary)

EX-3.1 — EXHIBIT 3.1 (dp250670_ex0301.htm)

EX-99.1 — EXHIBIT 99.1 (dp250670_ex9901.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: dp250670_8k.htm · Sequence: 1

false

--12-31

0001141103

2026-07-21

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________

Form 8-K

____________________________

Current Report

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 21, 2026

____________________________

Cross Country Healthcare, Inc.

(Exact name of registrant as specified in its

charter)

____________________________

Delaware

0-33169

13-4066229

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

5201 Congress Avenue, Suite 160, Boca Raton,

FL 33487

(Address of principal executive offices) (Zip

Code)

(561) 998-2232

(Registrant's telephone number, including area

code)

Not Applicable

(Former name or former address, if changed

since last report.)

____________________________

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.

of Form 8-K):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant

to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

CCRN

NASDAQ Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Introduction

July 21, 2026, pursuant to the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as

of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the “Company”), KL Criss Cross

Intermediate, LLC, a Delaware limited liability company (“Parent”), and KL Criss Cross Merger Sub, Inc., a Delaware

corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Company (the

“Merger”), with the Company surviving the Merger as a wholly-owned subsidiary of Parent.

Pursuant to the Merger Agreement, at the effective

time of the Merger (the “Effective Time”), each share of common stock of the Company, par value $0.0001 per share (“Company

Common Stock”) that was issued and outstanding immediately prior to the Effective Time (including the shares of Company Common

Stock subject to certain Company equity awards, as described in more detail below, but excluding (i) Company Common Stock held by the

Company as treasury shares or owned by Parent, Merger Sub or any other subsidiary of Parent immediately prior to the Effective Time and

(ii) Company Common Stock with respect to which appraisal rights are properly demanded and not withdrawn or lost under Section 262 of

the General Corporation Law of the State of Delaware) was automatically converted into the right to receive $13.25 in cash, without interest

and subject to any applicable withholding taxes (the “Merger Consideration”).

Effective as of immediately prior to the Effective

Time, each Company restricted stock award that was outstanding immediately prior to the Effective Time was fully vested, canceled and

converted into the right to receive an amount in cash equal to (i) the number of shares of Company Common Stock subject to such Company

restricted stock award immediately prior to the Effective Time multiplied by (ii) the Merger Consideration.

Effective as of immediately prior to the Effective

Time, each Company performance stock award that was outstanding immediately prior to the Effective Time was vested with performance as

of immediately prior to the Effective Time deemed to be achieved at the greater of target performance and actual performance, and each

such vested Company performance stock award was canceled and converted into the right to receive an amount in cash equal to (i) the number

of shares of Company Common Stock subject to such vested Company performance stock award immediately prior to the Effective Time (after

taking into account the performance in the manner set forth above) multiplied by (ii) the Merger Consideration.

The foregoing description of the Merger Agreement

and the transactions contemplated thereby, including the Merger, does not purport to be complete, and is subject to and qualified in its

entirety by reference to the full text of the Merger Agreement, which is incorporated by reference as Exhibit 2.1, to this Current Report

on Form 8-K.

Item 1.02. Termination of a Material Definitive Agreement.

Concurrently with the closing of the Merger, the

Company discharged all obligations and terminated all credit commitments, security interests and other liens outstanding under the ABL

Credit Agreement, dated October 25, 2019, by and among the Company, Wells Fargo Bank, National Association, as administrative and collateral

agent, and the lenders party thereto.

Item 2.01

Completion of Acquisition or Disposition of Assets.

The information set forth in the Introduction and

Item 1.02 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.

Item 3.01.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

The information set forth in the Introduction of

this Current Report on Form 8-K is incorporated by reference into this Item 3.01.

In connection with the consummation of the Merger,

the Company requested that The Nasdaq Stock Market LLC (“Nasdaq”) (i) suspend trading of Company Common Stock on Nasdaq

and remove Company Common Stock from listing on Nasdaq, in each case, prior to the opening of the market on July 21, 2026; and (ii) file

a notification of removal from listing of Company Common Stock on Form 25 with the Securities and Exchange Commission (“SEC”)

on July 21, 2026. As a result, trading of Company Common Shares on Nasdaq was suspended on July 21, 2026.

The Company intends to file Form 15 with the SEC

to terminate the registration of Company Common Stock under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange

Act”), and suspend the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act following the effectiveness

of such Form 25.

Item 3.03.

Material Modification to Rights of Security Holders.

The information set forth

in the Introduction, Item 1.02, Item 2.01, Item 3.01, Item 5.01, Item 5.02 and Item 5.03 of this Current Report on Form 8-K is incorporated

by reference into this Item 3.03.

At the Effective Time, each

holder of Company Common Stock immediately prior to the Effective Time ceased to have any rights as a Company shareholder other than the

right to receive the Merger Consideration pursuant to the Merger Agreement.

Item 5.01.

Changes in Control of Registrant.

The information set forth in the Introduction,

Item 1.02, Item 2.01, Item 3.01, Item 3.03, Item 5.02 and Item 5.03 of this Current Report on Form 8-K is incorporated by reference into

this Item 5.01.

At the Effective Time, a change in control of the

Company occurred, and the Company became a wholly-owned subsidiary of Parent. Parent obtained the funds necessary to fund the Merger through

a combination of cash on hand, including balance sheet cash of the Company, equity financing and debt financing.

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.

As of the Effective Time and as a result of the

completion of the Merger, the directors of Merger Sub became the sole directors of the Company. Accordingly, as of the Effective Time

and in accordance with the Merger Agreement, the following persons, constituting all the directors of the Company immediately prior to

the completion of the Merger, voluntarily resigned from the board of directors of the Company (the “Board”) and the

committees of the Board on which they served, if any, immediately prior to the Effective Time: Kevin C. Clark, W. Larry Cash, Venkat Bhamidipati,

Dwayne Allen, Gale Fitzgerald and Janice Nevin. These resignations were in connection with the Merger and not a result of any disagreements

between the Company and the resigning directors on any matter relating to the Company’s operations, policies or practices.

Additionally, as of the Effective

Time and as a result of the completion of the Merger, the officers of Merger Sub became the sole officers of the Company.

Item 5.03.

Amendment to Articles of Incorporation.

The information set forth

in the Introduction, Item 1.02, Item 2.01, Item 3.03, Item 5.01 and Item 5.02 of this Current Report on Form 8-K is incorporated by reference

into this Item 5.03.

Pursuant to the Merger Agreement, at the Effective Time, the articles

of incorporation of the Company were amended and restated and, upon the amendment and restatement, shall be the articles of incorporation

of the Company until further amended. A copy of the Company’s amended and restated articles of incorporation is attached as Exhibit

3.1 to this Current Report on Form 8-K and are incorporated by reference into this Item 5.03.

Item 8.01.

Other Events.

On July 21, 2026, Parent and

the Company issued a press release announcing the completion of the Merger, a copy of which is attached hereto as Exhibit 99.1 and incorporated

by reference into this Item 8.01.

Item 9.01.

Exhibits.

(d) Exhibits.

Exhibit

Number

Description

2.1

Agreement and Plan of Merger, dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., KL Criss Cross Intermediate, LLC and KL Criss Cross Merger Sub, Inc. 8-K (File No. 000-33169) filed on May 7, 2026).*

3.1

Second Amended and Restated Certificate of Incorporation of Cross Country Healthcare, Inc., dated July 21, 2026.

99.1

Press Release, dated July 21, 2026.

104

Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document

* Schedules and similar attachments have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted

schedule or similar attachment will be furnished to the SEC upon request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,

the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CROSS COUNTRY HEALTHCARE, INC.

Date: July 27, 2026

By:

/s/ Joel Tremblay

Name:

Joel Tremblay

Title:

Chief Executive Officer

EX-3.1 — EXHIBIT 3.1

EX-3.1

Filename: dp250670_ex0301.htm · Sequence: 2

Exhibit 3.1

SECOND AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

CROSS COUNTRY HEALTHCARE, INC.

* * * * * * * *

ARTICLE

One

The name of the corporation

is Cross Country Healthcare, Inc. (the “Corporation”).

ARTICLE

Two

The address of the registered

office of the Corporation in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware, 19801. The

name of the Corporation’s registered agent at such address is The Corporation Trust Company.

ARTICLE

Three

The nature of the business or

purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General

Corporation Law of the State of Delaware.

ARTICLE

Four

The total number of shares of

capital stock which the Corporation shall have authority to issue is 1,000 shares of common stock, $0.01 par value per share.

ARTICLE

Five

The Corporation shall have perpetual

existence.

ARTICLE

Six

In furtherance and not in limitation

of the powers conferred by statute, the board of directors of the Corporation (the “Board”) is expressly authorized

to make, alter, adopt, amend or repeal the Bylaws of the Corporation.

ARTICLE

Seven

Meetings of stockholders may

be held within or without the State of Delaware, as the Bylaws of the Corporation may provide. The books of the Corporation

may be kept outside the State of Delaware at such place or places as may be designated from time to time by the Board or as set forth

in the Bylaws of the Corporation. Election of directors need not be by written ballot unless the Bylaws of the Corporation

so provide.

ARTICLE

Eight

Except to the extent that the

General Corporation Law of the State of Delaware, as the same exists or may hereafter be amended, prohibits the elimination or limitation

of liability of directors for breaches of fiduciary duty, no director of the Corporation shall be personally liable to the Corporation

or its stockholders for monetary damages for any breach of fiduciary duty as a director. Any amendment or repeal of this Article

Eight shall not adversely affect any right or protection of a director of the Corporation under the General Corporation Law of the

State of Delaware existing at the time of such repeal or modification, and shall not apply to or have any effect on the liability or alleged

liability of any director with respect to any acts or omissions of such directors occurring prior to such amendment or repeal.

ARTICLE

Nine

The Corporation expressly elects

not to be governed by Section 203 of the General Corporation Law of the State of Delaware.

ARTICLE

Ten

The Corporation reserves the

right to amend, alter, change or repeal any provision contained in this certificate of incorporation in the manner now or hereafter prescribed

herein and by the laws of the State of Delaware, and all rights conferred upon stockholders herein are granted subject to this reservation.

ARTICLE

Eleven

The Corporation shall indemnify

to the fullest extent authorized or permitted by law, as now or hereafter in effect, any person made or threatened to be made a party

to any action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that such person or such

person’s testator or intestate is or was a director, officer or employee of the Corporation or any predecessor of the Corporation

or serves or served at any other enterprise as a director, officer or employee at the request of the Corporation or any predecessor to

the Corporation (each, an “Indemnified Person”). Such right to indemnification shall continue as to any such Indemnified

Person who has ceased to be a director, officer or employee of the Corporation or any predecessor of the Corporation or any such other

enterprise and shall inure to the benefit of such Indemnified Person’s heirs, executors and personal and legal representatives. The

right to indemnification conferred by this Article Eleven shall include the right to be paid by the Corporation the expenses incurred

in defending or otherwise participating in any proceeding in advance of its final disposition.

The Corporation may, to the

extent authorized from time to time by the Board, provide additional rights to indemnification and to the advancement of expenses to directors,

officers and employees and agents of the Corporation (subject to the final paragraph of this Article Eleven).

The rights to indemnification

and to the advance of expenses conferred in this Article Eleven shall not be exclusive of any other right which any person may

have or hereafter acquire under this certificate of incorporation, the Bylaws of the Corporation, any statute, agreement, vote of stockholders

or disinterested directors or otherwise.

Any repeal or modification of

the foregoing provisions of this Article Eleven by the stockholders of the Corporation shall not adversely affect any rights to

indemnification and to the advancement of expenses of any Indemnified Person existing at the time of such repeal or modification with

respect to any acts or omissions occurring prior to such repeal or modification.

ARTICLE

Twelve

In recognition and anticipation

that (i) the certain of the Covered Persons (defined below) may serve as directors or officers of the Corporation, (ii) the Sponsor (defined

below) and its Affiliated Companies (defined below) engage and may continue to engage in the same or similar activities or related lines

of business as those in which the Corporation, directly or indirectly, may engage and/or other business activities that overlap with or

compete with those in which the Corporation, directly or indirectly, may engage, and (iii) the Corporation and its Affiliated Companies

may engage in material business transactions with the Sponsor and its Affiliated Companies, and that the Corporation is expected to benefit

therefrom, the provisions of this Article Twelve are set forth to regulate and define the conduct of certain affairs of the Corporation

as they may involve the Covered Persons, and the powers, rights, duties and liabilities of the Corporation and its officers, directors

and stockholders in connection therewith.

The Corporation and its Affiliated

Companies renounce, to the fullest extent permitted by law, any interest or expectancy of the Corporation and its Affiliated Companies

in, or in being offered an opportunity to participate in, any Excluded Opportunity (as defined below). As a result of such

renunciation, (a) all Excluded Opportunities shall belong to the Sponsor and its Affiliated Companies, (b) no Covered Person shall have

any duty to present any Excluded Opportunity to the Corporation or its Affiliated Companies, (c) the Covered Persons shall have the right

to hold and exploit all Excluded Opportunities for their own account and benefit, or to direct, sell, assign or transfer any Excluded

Opportunity to any other person or entity and (d) the Covered Persons cannot be, and shall not be, liable to the Corporation, its stockholders

or its Affiliated Companies for breach of any fiduciary duty to the Corporation, its stockholders or its Affiliated Companies by reason

of the fact that any Covered Person does not present any Excluded Opportunity to the Corporation or its Affiliated Companies or pursues,

acquires or exploits any Excluded Opportunity for itself or directs, sells, assigns or transfers any Excluded Opportunity to any other

person or entity. Any person or entity purchasing or otherwise acquiring any interest in any shares of the Corporation shall

be deemed to have notice of and to have consented to the provisions of this Article Twelve.

To the extent that any provision

of this Article Twelve is found to be invalid or unenforceable, such invalidity or unenforceability shall not affect the validity

or enforceability of any other provision of this Article Twelve.

“Affiliated Company”

means (a) in respect of the Sponsor, (i) any entity that controls, is controlled by or is under common control with the Sponsor (other

than the Corporation and any company that is controlled by the Corporation) and (ii) any investment fund managed by the Sponsor or any

person or entity that controls, is controlled by or is under common control with the Sponsor and (b) in respect of the Corporation, any

company controlled by the Corporation.

“Covered Persons”

means (a) the Sponsor, its Affiliated Companies and any partner, member, director, officer, stockholder, employee or agent of the Sponsor

or any of its Affiliated Companies, and (b) any person serving as a director, officer, employee or agent of the Corporation at the request

of the Sponsor or any of its Affiliated Companies.

“Excluded Opportunity”

means any matter, transaction or interest or potential matter, transaction or interest (including without limitation those that might

be the same as or similar to the business or activities of the Corporation or any of its Affiliated Companies) that is presented to, or

acquired, created or developed by, or that otherwise comes into the possession of, any Covered Person unless such matter, transaction

or interest is offered in writing to a Covered Person expressly and solely in such Covered Person’s capacity as a director or officer

of the Corporation.

“Sponsor”

means Knox Lane LP.

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: dp250670_ex9901.htm · Sequence: 3

Exhibit 99.1

KNOX LANE COMPLETES ACQUISITION OF CROSS COUNTRY

HEALTHCARE

Appoints Joel Tremblay as Chief Executive Officer

SAN FRANCISCO and BOCA RATON, Fla. — July 21, 2026 —

Knox Lane, a growth-oriented investment firm, today announced the completion of its acquisition of Cross Country Healthcare, Inc. ("Cross

Country Healthcare" or the "Company"), a leading technology-enabled healthcare workforce solutions company.

In conjunction with the closing of the transaction, Joel Tremblay

has been appointed Chief Executive Officer of Cross Country Healthcare. Kevin C. Clark, Co-Founder, Chief Executive Officer, and

Chairman of the Board, will retire from his leadership roles and will support the Company and Mr. Tremblay to ensure a seamless transition.

Mr. Tremblay brings nearly two decades of leadership experience across

the healthcare workforce solutions industry. Most recently, he served as President of Medical Solutions, where he played a key role in

building and scaling one of the nation's largest clinical staffing organizations.

"I am honored to lead Cross Country Healthcare as it returns to

private ownership and enters its next phase of growth,” said Mr. Tremblay. “With its trusted brand, leading market presence,

and differentiated platform, the Company is uniquely positioned to help clients navigate workforce challenges and ensure access to quality

patient care. As a private company, we will have an enhanced ability to invest in innovation, strengthen our capabilities, and deliver

greater value to clients, healthcare professionals, and the communities we serve. I look forward to working alongside this talented team

to build upon the Company's strong foundation and drive long-term growth."

The completion of the transaction marks the beginning of a new era for

Cross Country Healthcare as a privately held, standalone company focused on advancing workforce solutions through continued investment

in technology, innovation, and operational excellence. As part of the transaction, Cross Country Healthcare's locums division has been

acquired by All Star Healthcare Solutions, a portfolio company of Knox Lane.

"Cross Country Healthcare occupies a distinctive position at the

intersection of healthcare workforce solutions and technology,” said John Bailey, Managing Partner at Knox Lane and Shamik Patel,

Partner at Knox Lane. “The Company has established a recognized market position, a trusted brand, and a differentiated platform

designed to address critical workforce challenges across the healthcare ecosystem. We’re thrilled to work with Joel again and look

forward to partnering with the entire Cross Country Healthcare team to accelerate innovation, expand capabilities, and create long-term

value for clients, healthcare professionals, and stakeholders.”

"I am incredibly proud of the Cross Country Healthcare team and

everything that we have accomplished. For more than four decades, Cross Country has been committed to helping healthcare organizations

address workforce challenges and ensure access to quality patient care,” said Mr. Clark. “This transaction marks an important

next step for the Company's future, and I am confident Knox Lane’s strategic partnership and Joel’s proven leadership will

support the Company’s growth and evolution. I look forward to seeing the organization build on its legacy of leadership while continuing

to serve clients and healthcare professionals with excellence."

Advisors

BofA Securities, Inc. served as exclusive financial advisor to Cross

Country Healthcare and delivered a fairness opinion to the Cross Country Healthcare Board of Directors. Davis Polk & Wardwell LLP

served as legal counsel to Cross Country Healthcare. MTS Health Partners served as exclusive financial advisor to Knox Lane and Kirkland

& Ellis LLP served as its legal counsel.

About Cross Country Healthcare

Cross Country Healthcare is a technology-driven healthcare workforce

solutions company that helps healthcare organizations solve complex labor challenges. Through its staffing, advisory, and workforce technology

capabilities, Cross Country supports health systems across nursing, allied health, and nonclinical service lines.

Through Intellify, its workforce intelligence platform, Cross Country

helps healthcare leaders gain greater visibility across workforce spend, supplier performance, labor demand, and operational execution,

supporting faster decisions and stronger workforce outcomes. Learn more at www.CrossCountry.com and www.Intellify.com.

About Knox Lane

Knox Lane is a growth-oriented investment firm based in San Francisco,

comprised of a team of accomplished investors and operators with a strong track record of partnering with leading companies to accelerate

growth. Knox Lane employs an investor-operator mindset and provides support across human capital, brand management, AI and digital transformation,

sourcing, supply chain and logistics, strategic acquisitions, and business development. For more information, visit www.knoxlane.com.

Media Contacts

Knox Lane

Erik Carlson / Woomi Yun

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449

Cross Country/Intellify

Karen Varga-Sinka

kvargasinka@crosscountry.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Jul. 21, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 21, 2026

Current Fiscal Year End Date

--12-31

Entity File Number

0-33169

Entity Registrant Name

Cross Country Healthcare, Inc.

Entity Central Index Key

0001141103

Entity Tax Identification Number

13-4066229

Entity Incorporation, State or Country Code

Entity Address, Address Line One

5201 Congress Avenue

Entity Address, Address Line Two

Suite 160

Entity Address, City or Town

Boca Raton

Entity Address, State or Province

Entity Address, Postal Zip Code

33487

City Area Code

561

Local Phone Number

998-2232

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

CCRN

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration